Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status
E.B. Faber, Y. Baca, J. Xiu, P. Walker, G. Manji, S. Gholami, A. Saeed, A. Prakash, G.P. Botta, D. Sohal, H.J. Lenz, A.F. Shields, C. Nabhan, W. El-Deiry, A. Seeber, V. Chiu, J. Hwang, E. Lou
Published in ESMO Gastrointestinal Oncology (01.06.2024)
Published in ESMO Gastrointestinal Oncology (01.06.2024)
Get full text
Journal Article